WAGNER CHARLES F JR (EVP and CFO) sold 6.4% of their position (3K shares) of VERTEX PHARMACEUTICALS INC / MA on the open market
Open‑market sale worth $1.55M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/13/2024ACC: 0000875320-24-000227
Officer· EVP and CFO
Since Apr 2019
-3K
Net shares
Net seller
$1.55M
Total sold
1
Open market trades
0B · 1S
1
Total transactions
3K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−3K
Price / share
$518.27
Trade value
$1.55M
% of position
6.4%
11/11/2024
47.14K→44.14K
Total
Net shares
−3K
Net value
-$1.55M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/11/2024 | S · Sale | −3K | $518.27 | $1.55M | 6.4% | 47.14K | 44.14K |
| Total | −3K | -$1.55M | ||||||
Derivative Transactions0
No derivative transactions reported